{
    "Trade/Device Name(s)": [
        "MRSASelect II",
        "MRSASelect\u2122II"
    ],
    "Submitter Information": "Bio-Rad Laboratories",
    "510(k) Number": "K171061",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081212",
        "K100589"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JSO"
    ],
    "Summary Letter Date": "November 30, 2017",
    "Summary Letter Received Date": "December 1, 2017",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1700"
    ],
    "Regulation Name(s)": [
        "Culture medium for antimicrobial susceptibility tests"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Methicillin-resistant Staphylococcus aureus (MRSA)"
    ],
    "Specimen Type(s)": [
        "Anterior nares",
        "Skin",
        "Soft tissue wound"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromogenic agar culture"
    ],
    "Methodologies": [
        "Selective and differential culture"
    ],
    "Submission Type(s)": [
        "Culture medium"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad MRSASelect II chromogenic medium for detection of MRSA from nasal and wound specimens",
    "Indications for Use Summary": "Qualitative detection of MRSA nasal colonization and MRSA from skin and soft tissue wound specimens to aid in prevention, control, and identification of MRSA infections in healthcare settings",
    "fda_folder": "Microbiology"
}